Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies.
about
The neural circuitry of executive functions in healthy subjects and Parkinson's diseaseA comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumParametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET ScannerEx Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors.Reproducibility of post-amphetamine [11C]FLB 457 binding to cortical D2/3 receptorsAmphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa.Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyHuman biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET.Imaging cognitive and behavioral symptoms in Parkinson's disease.Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders.Dopamine D3 receptor antagonists: a patent review (2007 - 2012).Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomographyTranslational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1.Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
P2860
Q33490981-589EE37F-68CA-4C00-A55A-25C2C2F93D93Q33861946-4D1CE39C-983E-4625-A746-D0A135C16D4BQ34362666-0A688618-EF19-4B97-8EDF-54BC062D2735Q34918396-A5C265C4-85CF-4D2A-8E27-9498271B1B5FQ35010421-E85CA886-B358-4149-BB1F-4A06D25E3129Q35151097-6859BAC7-9CD4-425A-8845-0374DDE47C9EQ36164564-429A27F8-3DFC-421E-9808-E9FB2658C565Q37701042-CF65F436-5481-4CF7-AA34-1AEF73B01DB6Q37810993-A0A24D09-F4D1-4B20-936E-FD7AC27DE8A5Q38056059-51E0F2E3-BC96-4C33-AB6F-4423CFF15521Q38071135-E47734A7-6B65-4F71-8482-452780DC5008Q38244707-4DAC0451-CAB1-4FE0-9E6E-F13DB7C5AA74Q49150668-6C416496-2F3F-4281-9E59-D2E9A599C15FQ50079750-551C6842-6917-4184-8C2C-484EC192FD40
P2860
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Positron emission tomography imaging of D
@nl
Positron emission tomography i ...... n and reproducibility studies.
@en
type
label
Positron emission tomography imaging of D
@nl
Positron emission tomography i ...... n and reproducibility studies.
@en
prefLabel
Positron emission tomography imaging of D
@nl
Positron emission tomography i ...... n and reproducibility studies.
@en
P2093
P2860
P356
P1433
P1476
Positron emission tomography i ...... on and reproducibility studies
@en
P2093
Brian J Lopresti
Charles M Laymon
Chester A Mathis
James M Mountz
Julie C Price
Maralee Litschge
N Scott Mason
Rajesh Narendran
Shivangi Vora
Steve Kendro
P2860
P304
P356
10.1002/SYN.20633
P577
2009-07-01T00:00:00Z